TP-PA predicate | Total number of samples | FTA-ABS | INNO-LIA | LIAISON | Trep-Sure | BioELISA | BIOLINE | CAPTIA (IgG) | Trep-ID | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R | NR | R | NR | R | NR | R | NR | R | NR | R | NR | R | NR | R | NR | ||
R | 109 | 103 | 6 (94.4) | 108 | 1 (99.1) | 109 | 0 (100) | 109 | 0 (100) | 109 | 0 (100) | 109 | 0 (100) | 109 | 0 (100) | 109 | 0 (100) |
NR | 181 | 0 | 181 (100) | 1 | 180 (99.4) | 1 | 180 (99.4) | 2 | 179 (98.9) | 2 | 179 (98.9) | 2 | 179 (98.9) | 5 | 176 (97.2) | 0 | 181 (100) |
FTA-ABS, fluorescent treponemal antibody-absorption; NR, non-reactive; R, reactive; TP-PA, treponema pallidum particle agglutination.